These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3093537)

  • 1. Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis.
    Peach SL; Borriello SP; Gaya H; Barclay FE; Welch AR
    J Clin Pathol; 1986 Sep; 39(9):1013-8. PubMed ID: 3093537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile in patients with cystic fibrosis.
    Welkon CJ; Long SS; Thompson CM; Gilligan PH
    Am J Dis Child; 1985 Aug; 139(8):805-8. PubMed ID: 4025261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Clostridium difficile and detection of cytotoxin in the feces of diarrheic foals in the absence of antimicrobial treatment.
    Jones RL; Adney WS; Shideler RK
    J Clin Microbiol; 1987 Jul; 25(7):1225-7. PubMed ID: 3112178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.
    Mahe S; Corthier G; Dubos F
    Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal carriage of Clostridium difficile in cystic fibrosis patients.
    Peach SL; Gaya H; Borriello SP
    Ann Ist Super Sanita; 1986; 22(3):953-7. PubMed ID: 3827000
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis.
    Wu TC; McCarthy VP; Gill VJ
    J Infect Dis; 1983 Jul; 148(1):176. PubMed ID: 6886480
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiological aspects of Clostridium difficile in a pediatric hospital and its role in diarrheal disease.
    Camorlinga-Ponce M; Gamboa M; Barragan JJ; Munoz O; Fekety FR; Torres JF
    Eur J Clin Microbiol; 1987 Oct; 6(5):542-6. PubMed ID: 3436315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
    Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
    J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clostridium difficile strains not producing Toxin A, but producing Toxin B [toxA(-)tox B(+)]--etiologic agent of antibiotic associated diarrhoea (AAD) in Poland].
    Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):45-53. PubMed ID: 12185683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis.
    Ellis ME; Mandal BK; Dunbar EM; Bundell KR
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):524-6. PubMed ID: 6421363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
    Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M
    Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feacal carriage of cytotoxigenic strains of Clostridium difficile by adult Nigerians.
    Rotimi VO; Akindutire D
    East Afr Med J; 1989 May; 66(5):319-23. PubMed ID: 2791928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile and cytotoxin in routine faecal specimens.
    Nash JQ; Chattopadhyay B; Honeycombe J; Tabaqchali S
    J Clin Pathol; 1982 May; 35(5):561-5. PubMed ID: 7085901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
    Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
    J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection.
    Burke DG; Harrison MJ; Fleming C; McCarthy M; Shortt C; Sulaiman I; Murphy DM; Eustace JA; Shanahan F; Hill C; Stanton C; Rea MC; Ross RP; Plant BJ
    J Cyst Fibros; 2017 Mar; 16(2):291-298. PubMed ID: 27908697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.